Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: A double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

European Heart Journal

Volumn 35, Issue 47, 2014, Pages 3356-3364

  Darkner, Stine ^a   Chen, Xu ^a   Hansen, Jim ^b   Pehrson, Steen ^a   Johannessen, Arne ^b   Nielsen, Jonas Bille ^a   Svendsen, Jesper Hastrup ^a,c,d  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ablation; Antiarrhythmic drugs; Atrial fibrillation

Indexed keywords

AMIODARONE; PLACEBO; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRADYCARDIA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART SINOATRIAL BLOCK; HOSPITALIZATION; HUMAN; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SLEEP DISORDER; TACHYCARDIA; TREATMENT DURATION; ATRIAL FIBRILLATION; CATHETER ABLATION; CLINICAL TRIAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TACHYCARDIA;

EID: 84924348629     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu354     Document Type: Article

References (16)

1. Cai L, Yin Y, LingZ, Su L, Liu Z, WuJ, DuH, Lan X, Fan J, ChenW, Xu Y, Zhou P, Zhu J, Zrenner B. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013; 164: 82-87
2. Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, WazniO, Burkhardt DJ, Raviele A, Natale A. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm 2008; 5: 679-685
3. WijffelsMC, Kirchhof CJ, Dorland R, AllessieMA.Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968
4. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; pii: S0735-1097(14)01740-9. doi: 10.1016/j.jacc.2014.03.022. [Epub ahead of print
5. Fuster V, Rydén LE, CannomDS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J-Y, KayGN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, JacobsAK, AdamsCD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc J-J, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, AmericanCollege of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of CardiologyCommittee for PracticeGuidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace2006; 8: 651-745
6. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997; 349: 667-674
7. McCullagh P, Nelder J. Generalized Linear Models. 2nd ed. Boca Raton: Chapman and Hall/CRC, 1989. ISBN 0-412-31760-5
8. Oral H, Knight BP, Ozaydin M, Tada H, Chugh A, Hassan S, Scharf C, Lai SWK, Greenstein R, Pelosi F Jr, Strickberger SA, Morady F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J Am Coll Cardiol 2002; 40: 100-104
9. Bertaglia E, Stabile G, Senatore G, Zoppo F, Turco P, Amellone C, De Simone A, Fazzari M, Pascotto P. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin Electrophysiol 2005; 28: 366-371
10. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen S-A, Crijns HJG, Damiano RJ, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim Y-H, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao H-M, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606
11. Roux J-F, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, Bala R, Dixit S, Riley M, Russo AM, Hutchinson MD, Cooper J, Verdino R, Patel V, Joy PS, Gerstenfeld EP. Antiarrhythmics after ablation of atrial fibrillation (5A study). Circulation 2009; 120: 1036-1040
12. Leong-Sit P, Roux J-F, Zado E, Callans DJ, Garcia F, Lin D, Marchlinski FE, Bala R, Dixit S, Riley M, Hutchinson MD, Cooper J, Russo AM, Verdino R, Gerstenfeld EP. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol 2011; 4: 11-14
13. Gu J, Liu X, Tan H, Zhou L, Gu J, JiangW, Wang Y, Liu Y. Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation. Acta Cardiol 2012; 67: 407-414
14. Malasana G, Day JD, Weiss JP, Crandall BG, Bair TL, MayHT, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Nelson J, Bunch TJ. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 761-766
15. Hayashi M, Miyauchi Y, Iwasaki Y-K, Yodogawa K, Tsuboi I, Uetake S, Hayashi H, Takahashi K, ShimizuW. Three-month lower-dose flecainide after catheter ablation of atrial fibrillation. Europace 2014; 16: 1160-1167
16. Channer KS, Birchall A, Steeds RP, Walters SJ, YeoWW, West JN, Muthusamy R, Rhoden WE, Saeed BT, Batin P, Brooksby WP, Wilson I, Grant S. A randomized placebo-controlled trial of pre-Treatment and short- or long-Term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. Eur Heart J 2004; 25: 144-150